top of page
Protecting Brain and
Vital Organ Health
in Neonates and Infants Worldwide
A Summary of
Challenges
Just 5 minutes
of inadequate oxygenation are enough to cause permanent brain damage.
46% of survivors
of severe prematurity suffer from life-long consequences.
At OxyPrem, we provide precise and accurate brain oxygen monitoring, so that medical teams can react before damage occurs.
Latest News
Crowd investing campaign crosses the 100% mark, remains open for investment
January 2025
Our crowd investing campaign at https://capitalcell.com/en/campaign/oxyprem/ has crossed the 100% mark. This means that the campaign will close successfully, latest on 28-FEB-2025.
The campaign remains open for investment beyond the 100% mark until it closes. Additional investors are welcome to join us and become a shareholder in OxyPrem.
Additional patent granting in China
December 2024
Another granting within the patent applications of the company's patent portfolio has occurred: For a patent already granted by the European Patent Office, the Chinese patent authorities have now granted it in China as well. This extends the range of granted patents to 3 (one in Europe and China, one in the US and China, and one in Europe).
Our Mission
Our non-invasive sensors offer real-time insight into tissue oxygen levels. This enables early intervention to prevent brain and other organ damage.
We are proud of our supporters
Long-standing wish
A next-generation device for high-technology tissue oximetry has been a long-standing request by the clinical community.
Fragile patients
Premature children belong to the most vulnerable patient groups and require extra careful handling and treatment.
bottom of page